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INTRODUCTION
Peripheral nerve hyperexcitability (PNH) is charac-
terized by spontaneous and continuous muscle activity, 
caused by hyperactive motor nerve terminal or neuro-
muscular junction. PNH can be associated with a variety 
of peripheral nerve disorders that can be inherited, auto-
immune, metabolic or toxic.1 Here we describe a patient 
of PNH following titanium marker placement during a 
breast biopsy.
CASE PRESENTATION
A 48 year-old Caucasian female with no prior medi-
cal history was noted to have microcalcifications in her 
left breast on mammogram. Biopsy revealed fibrocystic 
disease with no evidence of malignancy. During biopsy, 
a titanium marker was placed in the left breast for re-
peat imaging. One week later she developed stiffness in 
her heels while walking, followed by sensations of tingling 
in bilateral hands, bilateral feet and chest tightness. Within 
the following month, she noticed widespread muscle tight-
ness that was prominent at the initiation of limb movement 
and became less noticeable with repeated motion.  Frequent 
muscle spasms also appeared in her lower extremities.  Her 
exam revealed increased tone in bilateral lower extremi-
ties, mild weakness in distal arms and legs, diffuse hypore-
flexia, and prominent fasiculations in eyelids, tongue, and 
all extremities. Her lab work was significant for an elevated 
creatine kinase level of 885 U/L (reference range: 30-220 
U/L) and a low vitamin B12 level of 193 pg/mL (reference 
range: 221-700 pg/mL). Acetylcholine receptor and muscle 
specific receptor tyrosine kinase antibodies were negative. 
Electromyogram (EMG) showed persistent continuous 
motor unit activity during attempted relaxation, doublets 
and triplets, myokymic discharges and cramp potentials in 
essentially all examined muscles, indicative of PNH. Motor 
unit potential configurations were difficult to analyze due to 
overriding spontaneous activity but appeared unremark-
able. An extensive work up including inflammatory mark-
ers, heavy metal screening, serum paraneoplastic antibody 
panel, including voltage gated potassium channel antibod-
ies, glutamic decarboxylase antibodies, computed tomog-
raphy of chest; abdomen and pelvis was unrevealing. Cere-
brospinal fluid analysis was normal. She was treated with 
carbamazepine 200 mg twice daily which led to significant 
symptomatic relief within 1 week. Patient also took B12 sup-
plementation with correction of B12 levels subsequently.
The titanium marker was removed at 3 months, which 
led to no clinical improvement. The dose of carbamazepine 
was steadily increased to 200 mg four times a day and was 
associated with improvement in fasciculations, stiffness 
and gait. At 10 months, repeat EMG demonstrated a par-
tial improvement in the amount of spontaneous discharges. 
She was treated with 5 cycles of plasmapheresis which led 
to short-lived improvement of stiffness, fasciculations and 
gait. Prednisone at a daily dosage of 40 mg was initiated, 
resulting in improvement of stiffness and weakness. Sub-
sequently prednisone dose was gradually tapered. At 66 
months following the initial onset, she remained minimally 
symptomatic on a combination regime of prednisone 10 mg 
per day and carbamazepine 200 mg four times a day.  
DISCUSSION
Peripheral nerve hyperexcitability syndrome com-
monly results from ion channel dysfunction from either de-
creased potassium conduction or persistent sodium chan-
nel activity, or enhanced neuromuscular junction transmis-
sion from acetylcholinesterase inhibition. In our patient, an 
extensive work up for known causes of PNH was unreveal-
ing. While the possibility of coincidence cannot be totally 
excluded, the close temporal relationship between titanium 
marker placement and onset of PNH may indicate an asso-
ciation. There have been reports of PNH occurring second-
ary to heavy metal exposure such as gold, platinum, mer-
cury, lithium, and manganese.2-6 The mechanism of PNH in 
these cases is typically due to toxicity resulting in ion chan-
nel dysfunction or acetylcholinesterase inhibition.2-6
Titanium is used extensively in surgical and radiologi-
cal procedures due to its sustainability and biocompatible 
properties. It has been demonstrated that titanium may 
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alter the kinetics of voltage-gated potassium channel cur-
rents resulting in changes in neuron excitability.7 However, 
a direct toxicity of ion channel may not be the underlying 
mechanism of PNH in our patient, as removal of the titani-
um marker did not lead to significant improvement. Recent 
studies also suggested that metals such as titanium, nickel, 
mercury and gold could trigger systemic autoimmune or 
autoinflammatory syndromes in humans.8-9 The observed 
clinical improvement with prednisone and plasmapheresis 
treatment in our patient is supportive of an immune medi-
ated etiology. Given the widespread use of titanium in sur-
gical and radiologic procedures, clinicians should consider 
inquiring about titanium or other metal exposure in PNH 
syndromes. 
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